What is the treatment for hyponatremia (low sodium levels of 134 mEq/L) at the Emergency Department (ED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with a sodium level of 134 mEq/L in the Emergency Department, minimal intervention is typically required as this is only mildly decreased from the normal range (135-145 mEq/L).

Management Approach

The primary approach for asymptomatic patients with sodium of 134 mEq/L is observation and identification of underlying causes rather than immediate sodium correction 1.

  • If the patient is experiencing symptoms like headache, confusion, or nausea, initial management may include fluid restriction to 1-1.5 liters daily.
  • For more significant symptoms, cautious administration of hypertonic (3%) saline at 1-2 mL/kg/hr may be considered while monitoring sodium levels every 2-4 hours to prevent rapid correction.

Underlying Cause Addressed

The underlying cause should be addressed, which could include medication adjustment (particularly diuretics, antidepressants, or antipsychotics), treatment of underlying conditions like SIADH, heart failure, or cirrhosis, or correction of volume status 1.

Sodium Correction

Sodium correction should not exceed 8 mEq/L in 24 hours to avoid osmotic demyelination syndrome, as recommended by the most recent guidelines 1.

Specific Considerations

A sodium of 134 mEq/L is borderline low and often doesn't require aggressive treatment unless accompanied by significant symptoms or is rapidly declining. In patients with cirrhosis, the management of hyponatremia depends on the etiology, chronicity, severity, and urgency, with the goal of correcting sodium levels gradually to avoid osmotic demyelination syndrome 1.

From the Research

Treatment of Sodium Disorders

  • Sodium disorders, including hyponatremia and hypernatremia, are common findings in inpatient and outpatient settings, and are associated with an increased risk of morbidity and mortality 2.
  • The treatment of sodium disorders is based on symptoms and underlying causes, and may involve fluid restriction, isotonic saline, diuresis, or a combination of these therapies 2.

Treatment of Hyponatremia

  • Hyponatremia is treated with fluid restriction in the setting of euvolemia, isotonic saline in hypovolemia, and diuresis in hypervolemia 2.
  • Hypertonic saline is used to treat severe symptomatic hyponatremia, and medications such as vaptans may have a role in the treatment of euvolemic and hypervolemic hyponatremia 2, 3, 4.
  • The use of desmopressin and hypertonic saline has been shown to be a simple strategy for safe correction of severe hyponatremia, with a predictable response and minimal risk of overcorrection 5.

Management of Severe Hyponatremia

  • The management of severe hyponatremia requires careful consideration of the underlying cause and the risk of osmotic demyelination 6.
  • Infusion of hypertonic saline and desmopressin, or infusion of vasopressin inhibitors such as vaptans, may be used to correct severe hyponatremia, depending on the category of hyponatremia and the presence of concentrated or dilute urine 6.
  • Monitoring of changes in serum sodium concentration is imperative to guide treatment changes and prevent overcorrection of hyponatremia 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022

Research

Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.